NDC 80425-0004-01 - Cephalexin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0004
- Requested NDC
- 80425-0004-01
- Package NDCs from labels
- 80425-0004-1, 80425-0004-2, 80425-0004-3, 80425-0004-4, 80425-0004-5, 80425-0004-6, 80425-0004-7, 80425-0004-01
- Manufacturer
- ADVANCED RX PHARMACY OF TENNESSEE, LLC
- Effective date
- 2024-03-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cephalexin - ADVANCED RX PHARMACY OF TENNESSEE, LLC | ADVANCED RX PHARMACY OF TENNESSEE, LLC | 2024-03-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0004-1 | Cephalexin | 28 in 1 BOTTLE | CAPSULE | 28 | 5 | |
| 80425-0004-2 | Cephalexin | 40 in 1 BOTTLE | CAPSULE | 40 | 5 | |
| 80425-0004-3 | Cephalexin | 6 in 1 BOTTLE | CAPSULE | 6 | 5 | |
| 80425-0004-4 | Cephalexin | 5 in 1 BOTTLE | CAPSULE | 5 | 5 | |
| 80425-0004-5 | Cephalexin | 14 in 1 BOTTLE | CAPSULE | 14 | 5 | |
| 80425-0004-6 | Cephalexin | 20 in 1 BOTTLE | CAPSULE | 20 | 5 | |
| 80425-0004-7 | Cephalexin | 30 in 1 BOTTLE | CAPSULE | 30 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0004 | CEPHALEXIN CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 5 | Current NDC, Legacy NDC, 7 package rows | 20240314_af49507d-254f-296d-e053-2a95a90ad263.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0004-1 | EA - Each | 80425-0004 | 568b0d95-e053-4078-9588-aae633aac1c8 | 1 | 2023-03-13 |
| 80425-0004-2 | EA - Each | 80425-0004 | 08cd35d1-2cad-40a7-91fb-fdb8337d9e65 | 1 | 2023-03-13 |
| 80425-0004-3 | EA - Each | 80425-0004 | fbaf8b0f-38f5-4531-9f5b-26ccf9d8e766 | 1 | 2024-06-10 |
| 80425-0004-4 | EA - Each | 80425-0004 | 49b4d903-13ce-40d3-89cf-31cd97d711e7 | 1 | 2024-04-05 |
| 80425-0004-5 | EA - Each | 80425-0004 | 1020912e-44d0-4ba7-bbbc-b3ce215a7748 | 1 | 2024-04-05 |
| 80425-0004-6 | EA - Each | 80425-0004 | 88fa8483-8c3b-4c86-bbfe-68a6da75564f | 1 | 2024-04-05 |
| 80425-0004-7 | EA - Each | 80425-0004 | 9246bd25-019c-471d-a5b0-e435a401b8e4 | 1 | 2024-04-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cephalexin | CEPHALEXIN | PD-Rx Pharmaceuticals, Inc. | 6ce11859-aa21-4b3f-bd59-3cd26deca82b | 2025-11-07 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 5f867aa3-ea64-4a14-a63b-979b8ff8d80c | 2025-11-07 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 2070b988-f7fb-4e35-91e3-1b7df5e5326c | 2025-11-06 | Warnings, Adverse reactions | ANDA065253 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | AvPAK | 5975f293-8bb3-3242-aca7-d7d0c7e1bdc8 | 2025-10-30 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 21392758-c033-4d4d-81c9-d10e132f95b7 | 2025-10-18 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | bff3912c-c39c-40c0-98d2-27c3d506c24d | 2025-10-18 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | AMELLA PHARMA, LLC | 602fae70-3b8a-4f09-8db1-41fef4a2ecd7 | 2025-10-10 | Warnings, Adverse reactions | ANDA065253 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | f3b46058-3e53-413b-b9c9-7d49e50f861e | 2025-09-26 | Warnings, Adverse reactions | ANDA065253 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 88a744d8-a95e-4c63-8b25-52f5039b6ba1 | 2025-09-17 | Warnings, Adverse reactions | ANDA065253 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 8d7f247a-3b42-4823-96fb-5f5c1bd94d49 | 2025-08-29 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 1bfa8744-24ee-4c70-845c-c532b8084433 | 2025-07-29 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 0aad51b4-86d5-e312-e063-6394a90a250d | 2025-07-08 | Warnings, Adverse reactions | ANDA065253 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 50f0187b-09e7-4c11-970f-91cd1877fde1 | 2025-06-03 | Warnings, Adverse reactions | ANDA065253 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 905b3270-abbd-4d5c-b313-3d20eb4b4c57 | 2025-06-03 | Warnings, Adverse reactions | ANDA065253 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | f2e73727-2ab6-4418-9677-19ea1d140bbd | 2025-06-03 | Warnings, Adverse reactions | ANDA065253 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Coupler, LLC | 30b7071e-cef1-bd41-e063-6394a90ad48e | 2025-03-19 | Warnings, Adverse reactions | ANDA065253 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals, Inc. | 28da5822-fb0b-1306-e063-6394a90a6e4c | 2025-03-19 | Warnings, Adverse reactions | ANDA065253 OBN7UDS42Y |
| Orapaz | CEPHALEXIN, IBUPROFEN, CHLORHEXIDINE GLUCONATE | Brisk Pharmaceuticals | 2de0b332-58a3-0bb4-e063-6394a90a1a45 | 2025-02-11 | 309114 | |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 02b5cd6f-3df8-43c1-879d-217fcf55231a | 2025-02-11 | Warnings, Adverse reactions | ANDA065253 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 12f78d76-ea13-440c-8dd0-5aec86277acf | 2025-01-24 | Warnings, Adverse reactions | ANDA065253 OBN7UDS42Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.